- Home
- TK vs IMNM Comparison
TK vs IMNM Comparison
Compare TK & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- IMNM
- Stock Information
- Founded
- TK 1973
- IMNM 2006
- Country
- TK Bermuda
- IMNM United States
- Employees
- TK N/A
- IMNM N/A
- Industry
- TK Marine Transportation
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- TK Consumer Discretionary
- IMNM Health Care
- Exchange
- TK Nasdaq
- IMNM Nasdaq
- Market Cap
- TK 701.1M
- IMNM 748.3M
- IPO Year
- TK 1995
- IMNM 2020
- Fundamental
- Price
- TK $8.24
- IMNM $8.98
- Analyst Decision
- TK
- IMNM Strong Buy
- Analyst Count
- TK 0
- IMNM 5
- Target Price
- TK N/A
- IMNM $26.40
- AVG Volume (30 Days)
- TK 947.3K
- IMNM 828.5K
- Earning Date
- TK 07-31-2025
- IMNM 08-11-2025
- Dividend Yield
- TK 24.29%
- IMNM N/A
- EPS Growth
- TK 13.88
- IMNM N/A
- EPS
- TK 1.85
- IMNM N/A
- Revenue
- TK $1,086,963,000.00
- IMNM $10,938,000.00
- Revenue This Year
- TK N/A
- IMNM N/A
- Revenue Next Year
- TK N/A
- IMNM $310.65
- P/E Ratio
- TK $4.56
- IMNM N/A
- Revenue Growth
- TK N/A
- IMNM N/A
- 52 Week Low
- TK $5.65
- IMNM $5.15
- 52 Week High
- TK $9.78
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- TK 43.08
- IMNM 48.90
- Support Level
- TK $8.52
- IMNM $8.46
- Resistance Level
- TK $9.32
- IMNM $9.11
- Average True Range (ATR)
- TK 0.31
- IMNM 0.49
- MACD
- TK -0.11
- IMNM -0.10
- Stochastic Oscillator
- TK 8.26
- IMNM 28.75
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.